Novel nanopore-based technology helps detect pathogens among cancer patients rapidly and precisely

0

Analyses of the limits of detection of the nanopore amplicon sequencing assay in detecting Escherichia coli or Candida albicans of body fluid samples. (A, Correlations between the reads of the pathogen detected by nanopore amplicon sequencing and the dilution gradient of pathogens spiked in negative sputum; B, Correlations between the relative abundance of the pathogen detected by nanopore amplicon sequencing and the dilution gradient of pathogens spiked in negative sputum). Credit: Frontiers in Cellular and Infection Microbiology (2022). DOI: 10.3389/fcimb.2022.943859

A new method has been developed for the rapid detection of microbes from cancer patients. It was developed by a collaborated research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS).

The method, based on nanopore-based technology, was reported in an article in Frontiers in Cellular and Infection Microbiology.

Immunocompromised cancer patients are susceptible to various microbial infections and have a higher mortality rate than patients with other infections. Therefore, early identification of microorganisms is essential for the implementation of anti-infective therapy in patients.

In this study, the researchers collected samples from 56 immunocompromised cancer patients with suspicious infections. The samples included blood and sputum.

They isolated microbes and generated amplicon-based sequencing libraries, and sequenced the libraries utilizing the Oxford Nanopore MinION, a 90 g portable sequencer. Nanopore sequencing showed a significantly higher sensitivity than that of the conventional culture method. This advantage existed both in blood samples and non-blood samples.

Compared with traditional methods, the nanopore amplicon sequencing method showed more samples with bacterial infections, infections from fastidious pathogens, and co-infections. The mean turnaround time was approximately 17.5 hours, much shorter than the conventional culture assay.

“This method is rapid and accurate,” said Gu Hongcang, first author of the study, “it can detect pathogens among immunocompromised cancer patients with suspected infections.”

This novel and high-sensitive method would improve the prognosis of cancer patients with low immune function by facilitating the prompt diagnosis of infections and the implementation of timely and accurate anti-infective treatments.

More information:
Qingmei Deng et al, Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections, Frontiers in Cellular and Infection Microbiology (2022). DOI: 10.3389/fcimb.2022.943859

Provided by
Chinese Academy of Sciences


Citation:
Novel nanopore-based technology helps detect pathogens among cancer patients rapidly and precisely (2022, November 1)
retrieved 1 November 2022
from https://phys.org/news/2022-11-nanopore-based-technology-pathogens-cancer-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

FOLLOW us ON GOOGLE NEWS

 

Read original article here

Denial of responsibility! TechCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More